Compare J.B.Chemicals with STRIDES PHARMA SCIENCE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs STRIDES PHARMA SCIENCE - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

STRIDES PHARMA SCIENCE 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS STRIDES PHARMA SCIENCE J.B.CHEMICALS/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 17.6 7.4 237.1% View Chart
P/BV x 3.2 1.1 277.0% View Chart
Dividend Yield % 0.4 0.4 87.4%  

Financials

 J.B.CHEMICALS   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
STRIDES PHARMA SCIENCE
Mar-18
J.B.CHEMICALS/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs3631,147 31.7%   
Low Rs255642 39.7%   
Sales per share (Unadj.) Rs169.1317.2 53.3%  
Earnings per share (Unadj.) Rs16.67.8 211.6%  
Cash flow per share (Unadj.) Rs23.425.1 93.5%  
Dividends per share (Unadj.) Rs2.002.00 100.0%  
Dividend yield (eoy) %0.60.2 289.4%  
Book value per share (Unadj.) Rs172.5274.3 62.9%  
Shares outstanding (eoy) m83.5789.50 93.4%   
Bonus/Rights/Conversions BBESOP-  
Price / Sales ratio x1.82.8 64.8%   
Avg P/E ratio x18.6114.0 16.3%  
P/CF ratio (eoy) x13.235.7 37.0%  
Price / Book Value ratio x1.83.3 54.9%  
Dividend payout %12.025.5 47.3%   
Avg Mkt Cap Rs m25,82780,058 32.3%   
No. of employees `0003.82.5 150.5%   
Total wages/salary Rs m2,5114,341 57.9%   
Avg. sales/employee Rs Th3,747.411,325.8 33.1%   
Avg. wages/employee Rs Th665.71,731.4 38.4%   
Avg. net profit/employee Rs Th367.8280.1 131.3%   
INCOME DATA
Net Sales Rs m14,13528,394 49.8%  
Other income Rs m366941 38.9%   
Total revenues Rs m14,50129,334 49.4%   
Gross profit Rs m2,1783,965 54.9%  
Depreciation Rs m5701,540 37.0%   
Interest Rs m351,962 1.8%   
Profit before tax Rs m1,9401,403 138.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-168 0.0%   
Extraordinary Inc (Exp) Rs m0-436 0.0%   
Tax Rs m55297 567.6%   
Profit after tax Rs m1,387702 197.6%  
Gross profit margin %15.414.0 110.3%  
Effective tax rate %28.56.9 410.7%   
Net profit margin %9.82.5 396.9%  
BALANCE SHEET DATA
Current assets Rs m10,47024,836 42.2%   
Current liabilities Rs m2,74918,993 14.5%   
Net working cap to sales %54.620.6 265.4%  
Current ratio x3.81.3 291.3%  
Inventory Days Days5571 77.8%  
Debtors Days Days78113 68.5%  
Net fixed assets Rs m5,81134,289 16.9%   
Share capital Rs m167895 18.7%   
"Free" reserves Rs m14,24823,651 60.2%   
Net worth Rs m14,41624,546 58.7%   
Long term debt Rs m015,513 0.0%   
Total assets Rs m17,64965,437 27.0%  
Interest coverage x56.61.7 3,298.6%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.80.4 184.6%   
Return on assets %8.14.1 197.9%  
Return on equity %9.62.9 336.4%  
Return on capital %13.76.9 198.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,16415,697 39.3%   
Fx outflow Rs m1,334735 181.5%   
Net fx Rs m4,82914,962 32.3%   
CASH FLOW
From Operations Rs m1,2311,871 65.8%  
From Investments Rs m-2085,826 -3.6%  
From Financial Activity Rs m-595-10,157 5.9%  
Net Cashflow Rs m427-2,615 -16.3%  

Share Holding

Indian Promoters % 55.4 27.7 200.0%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 37.8 9.0%  
FIIs % 3.9 8.6 45.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 25.9 142.9%  
Shareholders   30,437 56,241 54.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   FULFORD INDIA  VENUS REMEDIES  STERLING BIOTECH  CADILA HEALTHCARE  AUROBINDO PHARMA  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

How to Trade this Market Crash(Podcast)

India's #1 trader, Vijay Bhambwani, decodes the crash...and reveals hidden opportunities one could profit from.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (2QFY20); Net Profit Up 2778.7% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 2 bn (up 2778.7% YoY). Sales on the other hand came in at Rs 7 bn (down 2.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY20); Net Profit Up 1048.1% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 432 m (up 1048.1% YoY). Sales on the other hand came in at Rs 7 bn (up 3.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (4QFY19); Net Profit Up 7919.8% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 650 m (up 7919.8% YoY). Sales on the other hand came in at Rs 8 bn (up 26.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

More Views on News

Most Popular

Multibaggers of the Next Decade(The 5 Minute Wrapup)

Feb 26, 2020

The one key ingredient to be seen amongst top multibaggers of the next decade.

The Next Few Days Are Crucial for Smallcap Investors - And 3 Must-Buy Stocks(Profit Hunter)

Feb 19, 2020

While I have been writing about the rebound in smallcaps for quite some time now... I have shied from the question - When exactly is the smallcap rebound happening. Well, the answer is now.

The Top 8 Trading Mistakes You Should Avoid(Fast Profits Daily)

Feb 18, 2020

Avoid these mistakes and your trading will turn much more profitable.

Corona Virus Could Trigger a Rally in this Stock(Profit Hunter)

Feb 20, 2020

A company which benefits from crude oil and coronavirus - if you would like to know more about it read this.

This is What You Must Know as an Options Trader Today(Fast Profits Daily)

Feb 27, 2020

How you can stay on top of the challenges as an options trader.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Feb 28, 2020 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - SUVEN LIFESCIENCES COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS